258 related articles for article (PubMed ID: 33675391)
1. Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review.
Yang R; Isaacs AM; Cadieux M; Hirmer TJ; CreveCoeur TS; Lapointe AP; Opoku-Darko M; Premji Z; Riva-Cambrin J; Gallagher CN
Childs Nerv Syst; 2021 Jun; 37(6):1849-1858. PubMed ID: 33675391
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
6. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
7. Variation in management of spinal gliobastoma multiforme: results from a national cancer registry.
Moinuddin FM; Alvi MA; Kerezoudis P; Wahood W; Meyer J; Lachance DH; Bydon M
J Neurooncol; 2019 Jan; 141(2):441-447. PubMed ID: 30460627
[TBL] [Abstract][Full Text] [Related]
8. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.
Lawton CD; Nagasawa DT; Yang I; Fessler RG; Smith ZA
J Neurosurg Spine; 2012 Nov; 17(5):438-48. PubMed ID: 22958073
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, treatment, and survival in spinal dissemination of primary intracranial glioblastoma: systematic literature review.
Wright CH; Wright J; Onyewadume L; Raghavan A; Lapite I; Casco-Zuleta A; Lagman C; Sajatovic M; Hodges TR
J Neurosurg Spine; 2019 Aug; 31(5):723-732. PubMed ID: 31374545
[TBL] [Abstract][Full Text] [Related]
11. Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
13. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.
Sakata J; Sasayama T; Tanaka K; Nagashima H; Nakada M; Tanaka H; Hashimoto N; Kagawa N; Kinoshita M; Nakamizo S; Maeyama M; Nishihara M; Hosoda K; Kohmura E
J Neurooncol; 2019 Apr; 142(2):241-251. PubMed ID: 30701354
[TBL] [Abstract][Full Text] [Related]
15. Disparities in health care determine prognosis in newly diagnosed glioblastoma.
Chandra A; Rick JW; Dalle Ore C; Lau D; Nguyen AT; Carrera D; Bonte A; Molinaro AM; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E16. PubMed ID: 29852776
[TBL] [Abstract][Full Text] [Related]
16. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
Ryu JY; Min KL; Chang MJ
PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
[TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
18. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
19. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
20. The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.
Tunthanathip T; Sangkhathat S; Tanvejsilp P; Kanjanapradit K
Clin Neurol Neurosurg; 2020 Aug; 195():105891. PubMed ID: 32480195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]